ELF
e.l.f. Beauty, Inc.78.77
+0.17+0.22%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q3 '26
Organic consumption dips to 6%
Q&A revealed organic consumption eased to 6% globally for 2H from prior 8% expectations, capping core growth at ~2% even as Rhode's $128M Q3 surge and outperformance drove a FY26 guide raise to 22-23% sales. UK softness stemmed from heavy promotions, prompting new EMEA leadership and targeted marketing tweaks. Rhode's international sales hovered near 20%, fueling disciplined expansions like Australia. e.l.f.'s 15% price hikes drew single-digit unit dips—resilience intact. Core business never healthier. Management stayed bullish on category tailwinds and spring innovation; investors will eye resets for momentum proof.
Key Stats
Market Cap
4.70BP/E (TTM)
56.26Basic EPS (TTM)
1.40Dividend Yield
0%Recent Filings
8-K
Appoints Farrell to board
e.l.f. Beauty appointed Matthew Farrell, ex-CEO of Church & Dwight, to its board as a Class I director effective February 12, 2026; he'll stand for election at the 2026 annual meeting. Farrell brings deep CPG and finance expertise from leading Church & Dwight and board roles at Trinseo, Morton Salt, and Novanta. No related arrangements. Standard director compensation applies.
10-Q
Q3 FY2026 results
e.l.f. Beauty surged to $489.5M net sales in Q3 FY2026 ended December 31, 2025, up 38% y/y from $355.3M, with gross margin steady at 71% despite tariff pressures offset by pricing and mix. Operating income climbed 93% y/y to $67.5M while diluted EPS rose to $0.65 from $0.30, reconciling to 60.2M shares. Rhode acquisition closed August 2025 for $897.5M (cash/equity/earnout), adding $128.2M sales and recognizing $512.2M goodwill plus $380.9M finite-lived intangibles (12-15 years). Cash hit $196.8M with $243.3M revolver availability, funding $110.1M operating cash flow (YTD) and $50M buybacks against $849.2M debt at ~5.9%. International sales doubled to $99.8M. Beauty stays brutally competitive.
8-K
Q3 sales +38%, outlook raised
e.l.f. Beauty reported Q3 fiscal 2026 net sales up 38% to $489.5M, with Adjusted EBITDA surging 79% to $123M despite gross margin dipping 30bps from tariffs. Nine-month sales rose 21% to $1,187.2M. Cash climbed to $196.8M, long-term debt to $816.7M. Raised FY2026 outlook to $1,600-1,612M sales. Momentum builds.
10-Q
Q2 FY2026 results
e.l.f. Beauty posted Q2 FY2026 net sales of $343.9M, up 14% y/y but operating income fell to $7.7M from $27.9M amid 69% gross margin (down from 71%, hit by tariffs). SG&A jumped 24% y/y to $231.1M on marketing and amortization from the rhode acquisition closed Aug 2025 for $896.5M (cash/equity/earnout), recognizing $511.2M goodwill and $380.9M finite-lived intangibles (12-15 years). Diluted EPS held at $0.05, matching shares outstanding. Cash swelled to $194.4M with $50.6M operating cash flow; total debt hit $856.7M at ~6.3% (Term Facility), revolver availability $243.3M. Rhode added $52.4M sales post-close. Beauty stays brutally competitive.
8-K
Q2 sales +14%, outlook issued
e.l.f. Beauty reported Q2 fiscal 2026 net sales up 14% to $343.9M, marking its 27th straight growth quarter, fueled by e.l.f. brand's 140bps market share gains and rhode's record Sephora launch. Gross margin slipped 1.65% to 69% from tariffs, while SG&A surged 67% to $231.1M on marketing and debt costs; GAAP net income fell to $3.0M. Fiscal 2026 guides 18-20% sales growth to $1.55-1.57B, yet adjusted EBITDA to $302-306M. Debt jumped to $831.6M.
IPO
Website
Employees
Sector
Industry
COTY
Coty Inc.
3.27-0.01
EL
Estee Lauder Companies, Inc. (T
104.39+3.36
HNST
The Honest Company, Inc.
2.86+0.05
NUS
Nu Skin Enterprises, Inc.
10.51+0.01
PG
Procter & Gamble Company (The)
145.21+0.08
SKIN
The Beauty Health Company
1.41+0.03
SKVI
SKINVISIBLE INC
0.43+0.00
UL
Unilever PLC
64.33-0.71
WALD
Waldencast plc
1.94+0.04
YSG
Yatsen Holding Limited
4.19-0.16